Leading Solutions for Newborn and Women’s Health
Delivering first-in-class medical devices and health management solutions for newborn and women’s health
At E3A Healthcare, we are at the forefront of innovation in medical devices for newborn and women’s healthcare. Established in 2019 on the campus of the National University of Singapore (NUS), our headquarters are in Singapore, with offices in Hong Kong and Shenzhen.
Our expertise lies in biosignal processing and biosensors, enabling us to develop first-in-class devices that enhance the accessibility and reliability of critical healthcare services. Since our inception, we have raised three rounds of venture capital financing, served over 250,000 families globally, and saved hundreds of newborns. Our esteemed investors include the National University of Singapore, Enterprise Singapore, Hong Kong X Fund (Sequoia China), Capital Asia Investments, and the City University of Hong Kong.
Our Products
E3A develops first-in-class medical devices for newborn and women’s health, creating innovative solutions that addresses overlooked demands.
Our Partners
Our Investors and Sponsors
News
Media Coverage
Contact Us
We're eager to hear from you! Get in touch with us and let's explore how our partnership can together deliver better care for families worldwide.
